Bibliography
- WENZEL SE, WESTCOTT JY, SMITH HR, LARSEN GL: Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am. Rev. Respir. Dis. (1989) 139(2):450–457.
- ••Highlighted the high levels of PGD2produced relative to other prostanoids.
- MCKENNIFF MG, RODGER IW, NORMAN P, GARDINER PJ: Characterisation of receptors mediating the contractile effects of prostanoids in guinea-pig and human airways. Eur. j Pharmacol (1988) 153(2-3):149–159.
- •Demonstrated that PGD2-induced airway smooth muscle contractions are mediated via TP receptors.
- MCKENNIFF MG, NORMAN P, CUTHBERT NJ, GARDINER PJ: BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro. Br. J. Pharmacol. (1991)104(3):585–90.
- GERVAIS FG, CRUZ RP, CHATEAUNEUF A et al.: Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DR J. Allergy Clin. Immunol (2001) 108(6):982–988.
- ••Clear demonstration of the differencesbetween these targets.
- GERVAIS FG, MORELLO J-P, BEAULIEU Get al.: Identification of a potent and selective synthetic agonist at the CRTH2 receptor. MoL Pharmacol (2005) 67:1834–1839.
- ULVEN T, KOSTENIS E: Minor structural modifications convert the dual TP/CRTH2 antagonist ramatroban into a highly selective and potent CRTH2 antagonist. J. Med. Chem. (2005) 48(4):897–900.
- ROBARGE MJ, BOM DC, TUMEY LN et al.: Isosteric ramatroban analogs: selective and potent CRTH2 antagonists. Bioorg Med. Chem. Lett. (2005) 15:1749–1753.
- SHIRAISHI Y, ASANO K, NAKAJIMA T et al.: Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. J. Pharmacol Exp. Ther. (2005) 312(3):954–960.
- MATHIESEN JM, ULVEN T, MARTINI Let al.: Identification of indole derivatives exclusively interfering with a G-protein-independent signaling pathway of the prostaglandin D2 receptor CRTH2. Mol Pharmacol (2005) 68:393–402.
- HATA AN, LYBRAND TP, MARNETT LJ et al.: Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2. MoL Pharmacol. (2005) 67:640–647.
- HATA AN, LYBRAND TP, BREYER RM: Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2. j Biol. Chem. (2005) 280:32442–32451.
- LY TW, BACON KB: Small-molecule CRTH2 antagonists for the treatment of allergic inflammation: an overview. Expert Opin. Investig Drugs (2005) 14:769–773.
- ARMER RE, ASHTON MR, BOYD EA et al.: Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2. J. Med. Chem. (2005) 48(20):6174–6177.
- MIMURA H, IKEMURA T, KOTERA 0 et al.: Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2. Pharmacol Exp. Ther. (2005) 314:244–251.